Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The Smart Drug Delivery Systems Market?

The market for intelligent drug delivery systems has witnessed a swift expansion in the past few years. There is a significant growth projected from $12.65 billion in 2024 to $15.06 billion in 2025, with a compound annual growth rate (CAGR) of 19.1%. The growth during the historical period was influenced by a rise in the demand for drug delivery systems, an increase in patient compliance, and a surge in chronic diseases, coupled with personalized medicine’s growth and the need for cost-effective healthcare solutions.

The market size for smart drug delivery systems is projected to quickly expand in the coming years, increasing to $29.19 billion in 2029 with a compound annual growth rate (CAGR) of 18.0%. This predicted growth during the forecast period can be associated with the escalating prevalence of non-communicable diseases, enhanced emphasis on precision medicine, the emergence of theragnostic, the rising necessity for non-surgical drug delivery techniques, and an uptick in healthcare spending. The forecast period is also expected to witness significant trends such as the advent of miniaturization and microfabrication technologies, advancements in the field of material science, the incorporation of artificial intelligence (AI) and machine learning (ML) techniques, the creation of nano-scale drug delivery systems, and the integration of the Internet of Things (IoT) and wearable technology into the sector.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14796&type=smp

What Market Forces Are Contributing To The Growth Of The Smart Drug Delivery Systems Market?

The smart drug delivery systems market is anticipated to expand due to the increasing incidence of chronic diseases. These diseases are long-lasting health issues that develop gradually and often have complicated origins. Factors such as an ageing population, environmental factors, and unequal healthcare accessibility contribute to the rise in chronic diseases. Smart drug delivery systems provide an effective way to manage these diseases by improving the efficiency of medications and enhancing patient compliance. For example, the National Library of Medicine, a medical library based in the US, reported in January 2023 that by 2050, the population suffering from at least one chronic disease is expected to hit 142.66 million, up 99.5% from 71.522 million in 2020. Consequently, the growth in the smart drug delivery systems market is being propelled by the rise in chronic diseases.

Which Segmentation Factors Are Critical In The Smart Drug Delivery Systems Market Analysis?

The smart drug delivery systemsmarket covered in this report is segmented –

1) By Product: Connected Inhalers; Connected Autoinjectors; Connected Pen Injectors; Connected Wearable Injectors; Add-On Sensors; Other Products

2) By Therapeutic Area: Metabolic Disorders; Neurological Disorders; Respiratory Disorders; Hormonal Disorders; Other Therapeutic Areas

3) By Drug Delivery Mode: Injectable; Inhalation; Oral

4) By End-User: Hospitals; Clinics; Home Care; Ambulatory Care Settings; Other End-Users

Subsegments:

1) By Connected Inhalers: Dry Powder Inhalers (DPIs); Metered Dose Inhalers (MDIs)

2) By Connected Autoinjectors: Single-Dose Autoinjectors; Multi-Dose Autoinjectors

3) By Connected Pen Injectors: Insulin Pen Injectors; Biologic Pen Injectors

4) By Connected Wearable Injectors: Insulin Wearable Injectors; Infusion Pump Wearable Injectors

5) By Add-On Sensors: Glucose Monitoring Sensors; Medication Adherence Sensors; Temperature Sensors

6) By Other Products: Smart Syringes; Smart Patches; Smart Implants

What New Opportunities Are Emerging From Trends In The Smart Drug Delivery Systems Market?

Prominent businesses in the intelligent drug delivery systems market are concentrating on creating reusable drug delivery gadgets, such as Qfinity, in order to transform drug dispensing. Unlike disposable devices which are thrown away after a single use, Qfinity is a reusable drug delivery instrument used for administering medication. For example, in May 2022, Jabil Inc., a US-based producer of manufacturing services, unveiled Qfinity, a reusable drug delivery apparatus specifically tailored for self-administration of drugs through subcutaneous injections. The apparatus can handle over 100 injections per device and is compatible with 1 mL or 2.25 mL pre-packed cartridges, leading to a 60% decrease in carbon emissions per injection. The Qfinity autoinjector system is adaptable, displaying extensive technical details for drug volumes and viscosities. Moreover, a linked model known as Qfinity+ allows for the remote supervision of patients’ healthcare and adherence due to the incorporated sensors and electronics, ensuring connectivity without sacrificing simplicity of application.

Which Organizations Are At The Forefront Of The Smart Drug Delivery Systems Market?

Major companies operating in the smart drug delivery systems market are Pfizer Inc., Johnson & Johnson, Bayer AG, Abbott Laboratories, Novartis International AG, Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk, Merck Group, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, Biogen Inc., Vertex Pharmaceuticals Incorporated, Phillips-Medisize Corporation, ResMed Inc., West Pharmaceutical Services Inc., Insulet Corporation, Owen Mumford Ltd., Sonceboz, H&T Presspart Manufacturing Ltd., E3D Elcam Drug Delivery Devices, CeQur Corporation

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/smart-drug-delivery-systems-global-market-report

Which Region Is Leading Innovation In The Smart Drug Delivery Systems Market?

North America was the largest region in the smart drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=14796&type=smp

Browse Through More Reports Similar to the Global Smart Drug Delivery Systems Market 2025, By The Business Research Company

Smart Phone Tablet Games Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-phone-tablet-games-global-market-report

Smart Home Security Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-home-security-global-market-report

Smart Home Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-home-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model